
Help accelerate research for
TTR Amyloidosis
See if you qualify to participate in this at-home research study today. Your contribution could help find new treatments.
By clicking continue, you agree to our privacy policy and terms and conditions consent to answer screening questions for potential enrollment in an active research study.
By clicking continue, you agree to our privacy policy and terms and conditions consent to answer screening questions for potential enrollment in an active research study.
Study Name:
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
This study is for people with:
wtATTR Amyloidosis or hATTR Amyloidosis
Number of participants:
10 participants
Sponsored By:
Sanguine Biosciences
Compensation:
$50
Purpose:
Your participation in this research study will aid in the development of more effective treatment options for patients living with wild-type and hereditary TTR Amyloidosis by allowing researchers to analyze biomarkers that may influence the disease’s development.
Length:
30-45 minutes
You may qualify if you:
- Are 18 years of age or older
- Have been diagnosed with or possess a genetic mutation linked to TTR amyloidosis (ATTR)
- Live in United States
You may not qualify if you:
- Are pregnant
- Have a known history of HIV, hepatitis or other infectious diseases
- Experienced excess blood loss including blood donation defined as 250 mL in the last month or 500 mL in the last two months
Participate from home!
United States
How it Works
It’s a simple, three-step process.

Submit a health profile by answering basic questions about your medical history.

Speak with a research coordinator to learn more about what is required to participate.

Complete study requirements from home with the help of our mobile health staff.
Who We Are
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research from home. Our goal is to develop mobile technologies that empower patients to participate in research for conditions that matter most to them, regardless of their location or ability to travel.
We work directly with patients and advocacy groups to accelerate research through convenience and transparency while guiding each patient every step of the way.
Sanguine's Expertise in Accelerating Research

our community

member has participated

completed by Sanguine
